Amedisys (AMED) Tops Q4 EPS by 18c; Issues FY23 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amedisys (AMED) Tops Q4 EPS by 18c; Issues FY23 Guidance

Amedisys Reports Fourth Quarter and Year-End 2022 Financial Results, Issues 2023 Guidance, Announces Sale of Its Personal Care Line of Business and Signs Innovative Palliative Care at Home Partnership

February 15, 2023 4:10 PM EST

BATON ROUGE, La., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2022.

Three-Month Periods Ended December 31, 2022 and 2021

Net service revenue increased $2.7 million to $562.0 million compared to $559.3 million in 2021.Net income attributable to Amedisys, Inc. of $31.7 million compared to $34.0 million in 2021.Net income attributable to Amedisys, Inc. per diluted share of $0.97 compared to $1.04 in 2021.... More